Sixteen patients were randomized: 9 were assigned to a standard diet for 6 days, while the other 7 followed an MCT-KD
Given the positive impact of GLP-1R agonists on a number of the pathophysiological traits of type 2 diabetes, including clinically significant reductions in body weight, this class of drug continues to expand with new analogs in development [1]
Suggested Dosage and Directions: Take 1 tbsp up to 3 times daily with a meal or as recommended by your qualified healthcare provider
Semaglutide seems to have a slight edge in reducing the risk of side effects, based on studies that assessed the risk of GI upset and pancreatitis.2 10 In our conversations with diabetic GLP-1 RA users, weve found that doctors will often start patients out on Ozempic, which uses the same active ingredient as Wegovy (semaglutide), as opposed to a drug based on tirzepatide
[DOI] [PubMed] [Google Scholar] 83.Fortin S.M., Lipsky R.K., Lhamo R., Chen J., Kim E., Borner T., Schmidt H.D., Hayes M.R